Zurich, Switzerland-based Rejuveron Life Sciences AG raised US$ 75 million in a Series B round and convertible loan offering. The funding was co-led by Catalio Capital Management and Apeiron Investment Group, the family office and private investment firm of entrepreneur Christian Angermayer. Catalio Capital Management is the life sciences-focused firm backed by hedge fund billionaires…